Insights & Publications

Explore by Category

The Private Equity Report Spring, 2019, Vol 19, No 1

DOJ Updates Guidance on Evaluating Corporate Compliance Programs

Federal Reserve Proposes Significant Changes to Foreign Bank Prudential Framework

Private Equity Guide to Consumer Product Investing Under the Trump Administration: Food and Drug Administration (FDA) Developments

See all Insights & Publications

Financial Regulatory Reform - Everything You Need to Know

Agencies Propose Significant Changes to Resolution Planning Requirements

Federal Reserve Proposes to Clarify and Revise Control Framework

Federal Reserve Proposes Significant Changes to Foreign Bank Prudential Framework

Updated DETER Act Introduced in the US Congress

Federal Cannabis Legislation Approved by House Financial Services Committee

U.S. Issues New North Korean and Syrian Shipping Advisories

Russian State Duma Adopts Bill on Digital Rights in Third Reading

2018/2019 Anti-Money Laundering Review and Outlook

U.S. Sanctions Against Venezuela Escalate: PdVSA Now Subject to Blocking Sanctions

Federal Reserve Previews New Insurance Holding Company Capital Requirements

Proposed Changes to Large Firm Prudential Framework

Bank Regulatory Relief To Become Law, Focus Shifts to Agencies

Assessing the Impact of U.S. Tax Reform

Base Erosion and Anti-Abuse Tax: Proposed Regulations Do Not Concede Much

IRS Guidance on Navigating the $1 Million Executive Compensation Deduction Limitation under Section 162(m)

New Guidance on 163(j) Business Interest Deductions

New Guidance on Withholding on Sales of Partnership Interests

Private Equity International: Tax Reform Leaves Firms Weighing Up the Possibilities

How the Tax Reform’s Changes to Section 162(m) Executive Compensation Rules Impact You

SEC Provides Guidance on Accounting Impacts of the Tax Cuts and Jobs Act

The Tax Cuts and Jobs Act Conference Report

The State of Healthcare & Life Sciences Under the Trump Administration

Private Equity Guide to Consumer Product Investing Under the Trump Administration: Food and Drug Administration (FDA) Developments

The Third Circuit Sharply Curtails the FTC’s Preferred Enforcement Power

Affordable Care Act Likely to Survive Latest Challenge

New Congress Brings Heightened Risk of Investigations for Life Sciences Companies

The 2018 Elections: Winners and Losers in the Healthcare Ecosystem

The White House’s Drug Pricing “Blueprint”

Private Equity Guide to Life Sciences Investing Under the Trump Administration: Food and Drug Administration (FDA) Developments

The Latest on the Trump Administration’s Drug Pricing Initiatives

Global View of Cybersecurity & Data Privacy Developments

German and EU Authorities Present First Ideas on the Regulation of Artificial Intelligence

Russian State Duma Adopts Bill on Digital Rights in Third Reading

GDPR Means Business: Google Hit with €50 Million Fine

Uber Fined over $1.1Million by EU Data Protection Authorities: Six Lessons Learned

Basel Committee Publishes Report on Cyber-Resilience Practices

SEC Investigation Report: Internal Accounting Controls Must be Calibrated to Cyber Risk

The Brazilian Data Protection Law - LGPD

What Not to Expect When You’re Expecting: UK Company Fined for Selling Mother and Baby Personal Data

The EU and Japan Announce Data Protection Deal

Privacy Law Goes Big: California’s New Consumer Privacy Act

Brexit Calling : Updates on the UK’s Departure from the European Union

European Funds Comment: EU Agrees Harmonised European Rules on Whistleblowing

European Funds Comment: EU Raises the Bar for Third-Country Access

EXPLORE FURTHER